1
189
7
3
1
| Cat. No. | Product Name | ||
|---|---|---|---|
| L8720 | 细胞焦亡化合物库 | 1077 compounds | |
| 1077 types of active small molecules associated with pyroptosis for high-throughput and high-content screening. | |||
| CL0084 | FGFR inhibitor kit | ||
| CL0117 | DPP4 inhibitor kit | ||
| L7300 | 钾通道分子库 | 160 compounds | |
| A unique collection of 160 potassium channel blockers and agonists for high throughput and high content screening; | |||
| L7600 | 趋化因子抑制剂库 | 59 compounds | |
| A unique collection of 59 chemokines or chemokine receptors targeted compounds for high throughput and high content screening; | |||
| L9500 | 表型筛选靶点鉴定库 | 1832 compounds | |
| A unique collection of 1832 annotated bioactive compounds with clear targets, suitable for phenotypic screening； | |||
| L9830 | 抗帕金森病化合物库 | 908 compounds | |
| A unique collection of 908 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS. | |||
| DO1200 | 药物靶点库 | ||
| L5900 | 血脑屏障通透化合物库 | 516 compounds | |
| A unique collection of 516 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L3700 | JAK-STAT 化合物库 | 256 compounds | |
| A unique collection of 256 JAK/STAT signaling targeted compounds for high throughput and high content screening; | |||
| L4000 | 经典已知活性库 | 12862 compounds | |
| TargetMol created the L4020 NO-PAINS Compound Library that applied the PAINS filter, remaining 12862 small molecules that are suitable for new drug development, signaling pathway research, drug repurposing and other research. | |||
| L1100 | 蛋白酶抑制剂库 | 344 compounds | |
| A unique collection of 344 protease and proteasome inhibitors for research in chemical genomics, and drug screening; | |||
| L3300 | 组胺&褪黑色素化合物库 | 155 compounds | |
| A unique collection of 155 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L1710 | 抗COVID-19化合物库 | 1160 compounds | |
| A unique collection of 1160 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents； | |||
| L2550 | 谷氨酰胺代谢化合物库 | 580 compounds | |
| A unique collection of 580 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and cancer; | |||
| L5500 | 毒性化合物库 | 277 compounds | |
| A unique collection of 277 toxic substances for high throughput screening (HTS) and high content screening (HCS); | |||
| L9410 | 共价抑制剂库 | 941 compounds | |
| A unique collection of 941 covalent Inhibitors and other molecules with common warheads like chloroacetyl，2-Chloropropionyl，Acryloyl，sulfonyl fluoride, alkyne，acrylamide, ketocarbonyl，disulfide bond, etc. | |||
| DC1170 | 特权片段注释化合物库-Oxidoreductases | ||
| CL0091 | MEK inhibitor kit | ||
| L3200 | 自噬库 | 1248 compounds | |
| A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L1000 | 上市药物库 | 2863 compounds | |
| A unique collection of 2863 approved drugs for high throughput screening (HTS) and high content screening (HCS); | |||
| L4900 | 心血管毒性化合物库 | 127 compounds | |
| A unique collection of 127 cardiotoxicity inducing compounds for toxicological study; | |||
| DC1150 | 特权片段注释化合物库-GPCR Family B | ||
| L2700 | 肾上腺素能受体化合物库 | 219 compounds | |
| A unique collection of 219 bioactive compounds specifically targeting adrenergic receptors, effective tool for screening new drugs or new target identification; | |||
| L2160 | 抗癌活性化合物库 | 2439 compounds | |
| A unique collection of 2439 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
| L7200 | 钙通道分子库 | 143 compounds | |
| A unique collection of 143 calcium channel blockers and agonists for high throughput and high content screening; | |||
| L2195 | 抗前列腺癌化合物库 | 2096 compounds | |
| 2096 compounds associated with prostate cancer that can be used for high-throughput and high-content screening. | |||
| DC1100 | 特权片段注释化合物库-GPCR Frizzled family | ||
| L8800 | 药物片段库 | 1158 compounds | |
| 1158 drug fragments，a must-have tool for FBDD; | |||
| CL0125 | AChE inhibitor kit | ||
| L1200 | 表观遗传库 | 960 compounds | |
| Well-chosen 960 compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L9411 | 半胱氨酸共价化合物库 | 72 compounds | |
| The cysteine covalent library contains 72 compounds. | |||
| L2110 | 抗癌上市药物库 | 1806 compounds | |
| A unique collection of 1806 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS); | |||
| L2200 | 酪氨酸激酶分子库 | 746 compounds | |
| A unique collection of 746 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related diseases; | |||
| L2130 | 抗癌细胞代谢库 | 1280 compounds | |
| A unique collection of 1280 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS); | |||
| L6700 | 抗癌天然产物库 | 1800 compounds | |
| A unique collection of 1800 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
| L8710 | 铜死亡化合物库 | 411 compounds | |
| TargetMol’s Cuproptosis Compound Library is a collection of 411 compounds related to copper-dependent death that can be used to study its mechanism and related diseases. | |||
| L2192 | 抗胰腺癌化合物库 | 2267 compounds | |
| A unique collection of 2267 pancreatic cancer related compounds can be used in HTS and HCS; | |||
| L6620 | 抗寄生虫天然产物库 | 233 compounds | |
| A unique collection of 233 natural products with antiparasitic activity, a powerful tool for high throughput screening (HTS) and high content screening (HCS); | |||
| L7820 | 高溶解性微型片段化合物库 | 1082 compounds | |
| The compound library of highly soluble micro-fragments consists of 1082 low-molecular-weight fragments. | |||
| CL0077 | Reverse Transcriptase inhibitor kit | ||
| L4660 | 神经疾病库Plus | 1246 compounds | |
| Well-chosen 1246 compounds with unique structures targeting nervous system; | |||
| L7000 | 活性脂质化合物库 | 385 compounds | |
| A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsa | |||
| L1310 | 细胞骨架化合物库 | 590 compounds | |
| A unique collection of 590 cytoskeleton-related compounds, can be used for HTS and HCS； | |||
| L6020 | 天然产物单体化合物库 | ||
| CL0071 | PDGFR inhibitor kit | ||
| L8600 | 泛素化化合物库 | 214 compounds | |
| A unique collection of 214 ubiquitination related small chemicals can be used for high throughput and high content screening； | |||
| LF1000 | 预制多样性库 | ||
| L7810 | 高溶解性多官能团片段化合物库 | 1159 compounds | |
| Highly soluble multifunctional fragment library contains 1159 kinds of fragment molecules. | |||
| DC1030 | 特权片段注释化合物库-Epigenetics | ||
| CL0141 | Notch pathway inhibitor kit | ||
| L1120 | AMPK靶向分子库 | 64 compounds | |
| 64 well-chosen unique AMPK-targeted small molecules； | |||
| L5300 | 线粒体靶向库 | 447 compounds | |
| A unique collection of 447 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine; | |||
| CL0116 | MAO inhibitor kit | ||
| L9230 | ReFRAME 相关化合物库 | 3274 compounds | |
| A unique collection of 3274 compounds for high-throughput screening and high-content screening, | |||
| L1380 | 转录因子库 | 704 compounds | |
| Well-chosen 704 compounds with unique structures targeting transcription factor; | |||
| L3900 | DNA 损伤和修复分子库 | 937 compounds | |
| A unique collection of 937 DNA Damage & Repair related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| CL0104 | NMDAR agonist/antagonist kit | ||
| L1110 | 微管靶向化合物库 | 80 compounds | |
| A unique collection of 80 microtubule-targeted compounds can be used in HTS and HCS; | |||
| L9850 | 口服活性化合物库 | 2484 compounds | |
| A unique collection of 2484 of orally active compounds for high-throughput screening and high-content screening. | |||
| DC1200 | 特权片段注释化合物库-Isomerases | ||
| DC1040 | 特权片段注释化合物库-Transferases | ||
| L5400 | 抗心血管疾病化合物库 | 1428 compounds | |
| A unique collection of 1428 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| DC1140 | 特权片段注释化合物库-Ligand-gated | ||
| L2196 | 抗卵巢癌化合物库 | 1888 compounds | |
| L7900 | 成骨分子库 | 320 compounds | |
| A unique collection of 320 osteogenesis related compounds for high throughput and high content screening; | |||
| L6150 | 天然产物共价化合物库 | 596 compounds | |
| Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening. | |||
| DC1190 | 特权片段注释化合物库-Sigma Opioid receptors | ||
| L6720 | 抗COVID-19中药单体库 | 1162 compounds | |
| A unique collection of 1162 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening； | |||
| L9810 | 抗纤维化化合物库 | 1180 compounds | |
| A unique collection of 1180 potential anti-fibrosis compounds, can be used in HTS and HCS; | |||
| L6610 | 抗感染天然产物库 | 1070 compounds | |
| A unique collection of 1070 species of natural products with anti-infective activity for high throughput screening (HTS) and high content screening (HCS); | |||
| L2194 | 抗结直肠癌化合物库 | 1565 compounds | |
| 1565 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening. | |||
| CL0079 | Adenosine Receptor inhibitor kit | ||
| L9400 | PPI抑制剂库 | 260 compounds | |
| A unique collection of 260 PPI-related compounds for drug screening; | |||
| CL0149 | β-/γ-secretase inhibitor kit | ||
| CL0138 | Carbonic Anhydrase inhibitor kit | ||
| L3500 | 组蛋白修饰化合物库 | 362 compounds | |
| A unique collection of 362 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L8700 | 铁死亡化合物库 | 800 compounds | |
| A unique collection of 800 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study； | |||
| L9610 | 环肽库 | 58 compounds | |
| 58 species of cyclic peptide molecules for high-throughput and high-content screening; | |||
| L5610 | Golden骨架库 | 10000 compounds | |
| Diversity: Selected from 1,600,000 drug-like compounds, 10000compounds representing 5000 scaffolds selected from a large drug-like chemical source； | |||
| DC1180 | 特权片段注释化合物库-Lyases | ||
| L9210 | 儿童药物库 | 1015 compounds | |
| A unique collection of 1015 pediatric drugs for high-throughput screening and high-content screening. | |||
| L9420 | 外泌体相关化合物库 | 54 compounds | |
| 54 exosome-related compounds that can be used for high-throughput and high-content screening. | |||
| CL0106 | HIF/HIF-PH inhibitor/activator kit | ||
| NY1000 | 天然产物衍生物库 | 4000 compounds | |
| The library consists of more than 4,000 members belonging 22 scaffolds (average 180 compounds per scaffold). | |||
| L1800 | 抗感染化合物库 | 2977 compounds | |
| A unique collection of 2977 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc; | |||
| L6400 | 海洋天然产物库 | 94 compounds | |
| A unique collection of 94 marine natural products for high throughput screening (HTS) and high content screening (HCS); | |||
| CL0130 | DUB inhibitor kit | ||
| L2151 | 化疗药物库 | 51 compounds | |
| 51 Chemotherapeutic drugs that can be used for high-throughput and high-content screening. | |||
| L7110 | 抗高血压化合物库 | 719 compounds | |
| 719 hypertension-related small molecules for high-throughput and high-content screening. | |||
| CL0113 | ER stress pathway inhibitor/inducer kit | ||
| L5700 | 精选片段库 | 246 compounds | |
| A unique collection of 246 fragment-like small molecules for FBDD; | |||
| L2120 | 抗癌临床化合物库 | 2359 compounds | |
| A unique collection of 2359 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L6010 | 天然产物库 | 3720 compounds | |
| A unique collection of 3720 natural products for high throughput screening (HTS) and high content screening (HCS); | |||
| L7860 | Mini片段亲电杂环化合物库 | 369 compounds | |
| 369 compounds in total in the Highly Solubility Covalent Heterocyclic Fragment Library | |||
| L2000 | 抑制剂库 | 7618 compounds | |
| A unique collection of 7618 inhibitors for research in cell signaling, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L7500 | 凝血与抗凝化合物库 | 154 compounds | |
| A unique collection of 154 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L2400 | 内分泌激素分子库 | 813 compounds | |
| A unique collection of 813 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L4150 | 新颖已知活性精选库 | 990 compounds | |
| It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties, structure-diversity, etc.) were chosen. This library consists of 990 compounds without compro | |||
| CL0082 | TRP Channel inhibitor kit | ||
| VM1400 | 多样性核心库Part2 | ||
| L6500 | 微生物天然产物库 | 254 compounds | |
| 254种微生物来源的生物活性小分子化合物的特有集合，用于高通量、高内涵筛选； | |||
| L8000 | 干细胞分化化合物库 | 1213 compounds | |
| A unique collection of 1213 stem cell differentiation signaling targeted compounds for high throughput and high content screening; | |||
| DC1050 | 特权片段注释化合物库-Voltage-gated | ||
| L6160 | Ro5类药天然产物库 | 2743 compounds | |
| A unique collection of 2743 natural product monomers that meet the "Lipinski's Rule of Five", a powerful tool for HTS and HCS screening; | |||
| L2100 | 抗癌化合物库 | 6854 compounds | |
| A unique collection of 6854 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
| L6810 | 中药单体化合物库 | 2688 compounds | |
| A unique collection of 2688 compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism； | |||
| CL0089 | c-Met/HGFR inhibitor kit | ||
| DC1010 | 特权片段注释化合物库-GPCR Family A | ||
| CL0097 | Prostaglandin Receptor antagonist/agonist kit | ||
| L6120 | 黄酮类天然产物库 | 477 compounds | |
| A unique collection of 477 flavonoids can be used for high throughput and high content screening； | |||
| L2510 | 脂代谢化合物库 | 496 compounds | |
| A unique collection of 496 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS). | |||
| DC1160 | 特权片段注释化合物库-Toll-like and Il-1 receptors | ||
| CL0075 | c-Kit inhibitor kit | ||
| L5510 | 肝脏毒性化合物库 | 1040 compounds | |
| A unique collection of 1040 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening； | |||
| L4600 | 植物来源化合物库 | 3076 compounds | |
| A unique collection of 3076 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS); | |||
| L6130 | 萜类天然产物库 | 349 compounds | |
| A unique collection of 349 natural terpenes and terpenoids can be used for high throughput and high content screening； | |||
| L2800 | 5-羟色胺分子库 | 275 compounds | |
| A unique collection of 275 compounds targeting serotonin receptors for high throughput screening and high content screening; | |||
| CL0059 | Dopamine Receptor inhibitor kit | ||
| CL0092 | GSK-3 inhibitor kit | ||
| L3510 | 甲基化化合物库 | 131 compounds | |
| 131 methylation-related compounds that can be used for high-throughput and high-content screening. | |||
| L2530 | 小鼠代谢化合物库 | 224 compounds | |
| A unique collection of 224 mouse metabolites, which can be used for HTS and HCS; | |||
| L8300 | 染色质修饰分子库 | 256 compounds | |
| A unique collection of 256 compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS); | |||
| L6030 | 天然产物衍生物虚筛化合物库 | ||
| L7850 | 高溶解性3D结构多样性片段化合物库 | 1081 compounds | |
| The library of highly soluble 3D structural diversity fragments contains 1081 compounds. | |||
| DC1060 | 特权片段注释化合物库-Kinases | ||
| L6220 | 蒙药化合物库 | 960 compounds | |
| A collection of 960 natural product molecules originated from Mongolian medicine, which can be used for high-throughput and high-content screening. | |||
| CL0072 | BET inhibitor kit | ||
| L9600 | 多肽分子库 | 533 compounds | |
| 533 peptides can be used in peptide drug development and signaling transduction and mechanism study; | |||
| L7840 | 高溶解性卤化片段化合物库 | 796 compounds | |
| The highly soluble halogenated fragment library contains 796 halogenated fragment compounds. | |||
| CL0139 | ROS inhibitor kit | ||
| L5600 | Mini骨架库 | 5033 compounds | |
| Diversity: Selected from 1,600,000 drug-like compounds covering rich chemical scaffolds, 5033 compounds representing 5033 scaffolds； | |||
| CL0087 | mTOR inhibitor kit | ||
| L7700 | 神经再生化合物库 | 529 compounds | |
| A unique collection of 149 neuroregeneration related compounds for high throughput and high content screening; | |||
| L6600 | 胃肠炎天然产物库 | 223 compounds | |
| A unique collection of 223 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS); | |||
| DP9100 | CB1-2化合物库 | ||
| CL0121 | ALK inhibitor kit | ||
| DC1220 | 特权片段注释化合物库-Aminoacyltransferases | ||
| CL0100 | Raf inhibitor kit | ||
| L2610 | 神经递质受体化合物库 | 1513 compounds | |
| A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening； | |||
| L2600 | 神经信号分子库 | 2011 compounds | |
| A unique collection of 2011 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| CL0122 | ACE inhibitor kit | ||
| L9820 | β-内酰胺类化合物库 | 105 compounds | |
| A unique collection of 105 beta-lactam compounds, can be used in HTS and HCS; | |||
| DC1000 | 特权片段注释化合物库 | ||
| L2540 | 肠道微生物代谢化合物库 | 352 compounds | |
| A unique collection of 352 gut microbial metabolites which can be used for HTS and HCS; | |||
| L7830 | 高溶解性片段药效团化合物库 | 985 compounds | |
| High Solubility Pharmacophore Fragment library contains 985 fragment small molecules. | |||
| CL0143 | PKA/cAMP inhibitor/activator kit | ||
| L2900 | 氧化还原化合物库 | 1279 compounds | |
| 1279 small molecule compounds with pro-oxidant or anti-oxidant activity for high-throughput and high-content screening. | |||
| L9100 | 磷酸酶抑制剂化合物库 | 80 compounds | |
| A collection of 80 phosphatase inhibitors with known activity; | |||
| CL0126 | Androgen Receptor antagonist kit | ||
| CL0144 | Endothelin Receptor antagonist kit | ||
| L8100 | 细胞周期化合物库 | 695 compounds | |
| A unique collection of 695 cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L2300 | 离子通道库 | 946 compounds | |
| A unique collection of 946 compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery; | |||
| L4500 | 抗真菌库 | 253 compounds | |
| A unique collection of 253 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation. | |||
| DC1110 | 特权片段注释化合物库-Proteases | ||
| L2560 | 代谢化合物库 | 2350 compounds | |
| A unique collection of 2350 metabolic pathway-related bioactive small molecule compounds for high-throughput, high-content screening. | |||
| L6710 | 中药抗炎分子库 | 1260 compounds | |
| A collection of 1260 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study； | |||
| CL0085 | HSP inhibitor kit | ||
| L2520 | 糖代谢化合物库 | 708 compounds | |
| 708 glycometabolism-related comounds, can be used for HTS and HCT; | |||
| L1720 | 核苷类化合物库 | 337 compounds | |
| A unique collection of 337 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs; | |||
| CL0107 | Src inhibitor/activator kit | ||
| CL0046 | 5-HT Receptor antagonist/agonist kit | ||
| L4400 | 抗生素库 | 708 compounds | |
| A unique collection of 708 compounds with antibiotic activity for new antibacterial drug screening; | |||
| DC1210 | 特权片段注释化合物库-Phosphatases | ||
| L6110 | 生物碱类天然产物库 | 468 compounds | |
| A unique collection of 468 natural alkaloids can be used for high throughput and high content screening； | |||
| DP1300 | h-TERT靶向化合物库 | ||
| L9840 | 抗阿尔茨海默症化合物库 | 1040 compounds | |
| A unique collection of 1040 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS. | |||
| L2570 | 人代谢物化合物库 | 4532 compounds | |
| A unique collection of 4532 human metabolites for high-throughput, high-content screening. | |||
| L9200 | 药物功能重定位化合物库 | 4240 compounds | |
| A unique collection of 4240 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS); | |||
| DC1130 | 特权片段注释化合物库-Phosphodiesterases | ||
| L4100 | TGF-β/Smad靶点化合物库 | 180 compounds | |
| A unique collection of 180 TGF-beta/Smad signaling targeted compounds for high throughput and high content screening; | |||
| L3100 | 造血毒性小分子库 | 104 compounds | |
| A unique collection of 104 compounds with defined hematopoietic toxicity for high throughput and high content drug screening; | |||
| L6100 | 天然多酚类化合物库 | 640 compounds | |
| A unique collection of 640 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L8200 | 抗衰老化合物库 | 3324 compounds | |
| A unique collection of 3324 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L6300 | 药食同源库 | 1088 compounds | |
| A unique collection of 1088 compounds from food as medicine for high throughput and high content screening; | |||
| DC1090 | 特权片段注释化合物库-Ligases | ||
| CL0110 | Progesterone Receptor agonist/antagonist/modulator kit | ||
| L4520 | 抗菌活性库 | 921 compounds | |
| A unique collection of 921 antibacterial bioactive compounds, a powerful tool for antibacterial drug development; | |||
| CL0111 | TLR agonist/antagonist kit | ||
| L9000 | 细胞凋亡化合物库 | 1796 compounds | |
| A unique collection of 1796 apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening; | |||
| L9300 | 大环化合物库 | 216 compounds | |
| 216种活性已知的大环化合物，用于高通量、高内涵筛选； | |||
| L1010 | FDA上市及药典收录分子库 | 3158 compounds | |
| 3158个上市及药典分子集合，可用于高通量筛选和高内涵筛选； | |||
| DC1230 | 特权片段注释化合物库-Beta amyloid A4 protein | ||
| L2500 | 人内源代谢化合物库 | 1400 compounds | |
| A unique collection of 1400 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening; | |||
| L3980 | DNA损伤/修复库Plus | 667 compounds | |
| Well-chosen 667 compounds with unique structures targeting DNA damage & repair; | |||
| CL0093 | PARP inhibitor kit | ||
| CL0112 | PKC inhibitor kit | ||
| L1510 | 核受体化合物库 | 420 compounds | |
| A unique collection of 420 nuclear receptor signaling targeted compounds for high throughput and high content screening; | |||
| L5100 | 含氟化合物库 | 583 compounds | |
| A unique collection of 583 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS); | |||
| Cat. No. | Product Name | Form | Specificity Of Inhibition |
|---|---|---|---|
| C0005 |
Cell Counting Kit-8 (CCK-8)
Cell Counting Kit-8 (CCK-8) |
||
| C0004 |
Phosphatase Inhibitor Cocktail III (2 Tubes, 100x)
磷酸酶抑制剂 Cocktail III |
||
| C0003 |
Phosphatase Inhibitor Cocktail II (100× DMSO)
磷酸酶抑制剂 Cocktail II |
||
| C0008 |
SYBR Green qPCR Master Mix (Low ROX)
SYBR Green qPCR Master Mix (Low ROX) |
||
| C0001 |
Protease Inhibitor Cocktail
蛋白酶抑制剂 Cocktail |
||
| C0045 |
RIPA Lysis Buffer (Strong)
RIPA Lysis Buffer (Strong) |
||
| C0002 |
Phosphatase Inhibitor Cocktail I (100× ddH2O)
磷酸酶抑制剂 Cocktail I |
| Cat. No. | Product Name | ||
|---|---|---|---|
| EC2000 | 全自动封板仪 | ||
| Cat. No. | Product Name | ||
|---|---|---|---|
| EC3000 | TargetMol® 24 道磁力架 | ||
| EC4000 | TargetMol® 高通量开盖器 | ||
| P-0.4-96U | Agen 96孔 0.4mL圆孔微孔板，U型底 | ||
| Cat. No. | Product Name | Target | Signaling Pathways |
|---|---|---|---|
| TN3064 | 4'-O-Methylvitexin | Others | Others |
沪公网安备 31010602006700号
